IN42: Severe IN42: , sepsis, and systemic and cerebral inflammatory response
IN42: Severe IN42: , sepsis, and systemic and cerebral inflammatory response
El grupo de investigación centra su actividad en la realización de estudios clínicos sobre la respuesta inflamatoria y marcadores biológicos en las infecciones graves de pacientes críticos.
Responsible researcher
- Mikel Celaya Lopez:
- E-mail: mikel.celaya.sspa@juntadeandalucia.es
- ORCID: 0000-0002-9868-8880
Lines of research
- Line 1: Serious infections.
- Line 2: Pneumonia.
- Line 3: Bacteremia.
- Line 4: Sepsis.
- Line 5: Infection prevention and control in the ICU.
- Line 6: Diagnosis of serious infections.
- Line 7: Diagnostic biomarkers.
- Line 8: Response to antimicrobial therapy.
Keywords
- # Infections in critically ill patients
- # Pneumonia
- # Bacteremia
- # Sepsis
- # Inflammatory response
IN42: Severe IN42: , sepsis, and systemic and cerebral inflammatory response
IN42: Severe IN42: , sepsis, and systemic and cerebral inflammatory response
Responsible researcher
Mikel Celaya López:
Head of Intensive Care Medicine at Hospital Universitario Puerta del Mar.
- E-mail: mikel.celaya.sspa@juntadeandalucia.es
- ORCID: 0000-0002-9868-8880
Team Members
- Principal Investigators:
- Mikel Celaya López (PI).
- Researchers:
- Antonio Gordillo Brenes.
- Maria Dolores Freire Aragon.
- Julia Mercedes Salas Martin.
- Ana Fernández Cuervo.
- Alejandra Patricia Garrino.
- Mario Raúl Contreras Virués.
- Alicia Cuadra Calahorra.
- Jaume Revuelto Rey.
- Fatima Rivas Gomez-Plana.
- Juan Francisco Brea Salvago.
IN42: Severe IN42: , sepsis, and systemic and cerebral inflammatory response
IN42: Severe IN42: , sepsis, and systemic and cerebral inflammatory response
Production
Find all of the group's work (their Projects, Patents Publications) on the Andalusian Public Health System's I+Salud Portal:
